Clinical Trial Update: Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial investigating pharmacogenomic-guided tacrolimus dosing and monitoring in kidney transplant recipients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Renal Transplant

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Renal Transplant | Phase 4 | Status: COMPLETED | Results posted: 2022-07-21